State Street Corp Fibrogen Inc Transaction History

State Street Corp

$2.47 Trillion
Q4 2024

A detailed history of State Street Corp transactions in Fibrogen Inc stock. As of the latest transaction made, State Street Corp holds 343,053 shares of FGEN stock, worth $264,150. This represents 0.0% of its overall portfolio holdings.

Number of Shares

343,053

Previous 342,163 0.26%

Holding current value

$264,150

Previous $136,000 33.09%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$0.3 - $0.58 $267 - $516	890 Added 0.26%	343,053 $181,000
Q3 2024 Nov 14, 2024	SELL	$0.33 - $1.26 $15,741 - $60,102	-47,700 Reduced 12.24%	342,163 $136,000
Q2 2024 Aug 14, 2024	SELL	$0.89 - $2.36 $1.58 Million - $4.18 Million	-1,773,014 Reduced 81.97%	389,863 $346,000
Q1 2024 May 15, 2024	BUY	$0.73 - $2.73 $257,103 - $961,497	352,197 Added 19.45%	2,162,877 $5.08 Million
Q4 2023 Feb 14, 2024	BUY	$0.38 - $0.91 $39,827 - $95,376	104,809 Added 6.14%	1,810,680 $1.61 Million
Q3 2023 Nov 14, 2023	SELL	$0.79 - $2.83 $2.61 Million - $9.36 Million	-3,308,338 Reduced 65.98%	1,705,871 $1.47 Million
Q2 2023 Aug 14, 2023	BUY	$2.49 - $20.59 $2.34 Million - $19.3 Million	938,042 Added 23.01%	5,014,209 $13.5 Million
Q1 2023 May 15, 2023	SELL	$15.95 - $25.18 $3.01 Million - $4.75 Million	-188,810 Reduced 4.43%	4,076,167 $76.1 Million
Q4 2022 Feb 14, 2023	BUY	$13.27 - $17.73 $537,793 - $718,543	40,527 Added 0.96%	4,264,977 $68.3 Million
Q3 2022 Nov 15, 2022	SELL	$11.4 - $14.6 $4.37 Million - $5.6 Million	-383,667 Reduced 8.33%	4,224,450 $55 Million
Q2 2022 Aug 15, 2022	SELL	$7.94 - $12.96 $2.54 Million - $4.14 Million	-319,664 Reduced 6.49%	4,608,117 $48.7 Million
Q1 2022 May 16, 2022	BUY	$12.02 - $16.79 $5.06 Million - $7.07 Million	420,828 Added 9.34%	4,927,781 $59.2 Million
Q4 2021 Feb 14, 2022	SELL	$9.93 - $15.39 $19.9 Million - $30.9 Million	-2,006,122 Reduced 30.8%	4,506,953 $63.5 Million
Q3 2021 Nov 15, 2021	BUY	$10.18 - $26.64 $31.5 Million - $82.4 Million	3,091,859 Added 90.37%	6,513,075 $66.6 Million
Q2 2021 Aug 16, 2021	BUY	$18.57 - $35.68 $7.43 Million - $14.3 Million	400,207 Added 13.25%	3,421,216 $91.1 Million
Q1 2021 May 17, 2021	SELL	$31.0 - $55.72 $5.04 Million - $9.06 Million	-162,646 Reduced 5.11%	3,021,009 $105 Million
Q4 2020 Feb 16, 2021	BUY	$37.09 - $48.97 $14.1 Million - $18.6 Million	380,563 Added 13.58%	3,183,655 $118 Million
Q3 2020 Nov 10, 2020	SELL	$40.47 - $45.5 $12.4 Million - $13.9 Million	-305,948 Reduced 9.84%	2,803,092 $115 Million
Q2 2020 Aug 14, 2020	BUY	$32.57 - $42.83 $14.6 Million - $19.1 Million	447,002 Added 16.79%	3,109,040 $126 Million
Q1 2020 May 11, 2020	BUY	$23.3 - $45.96 $62 Million - $122 Million	2,662,038 New	2,662,038 $92.5 Million

Others Institutions Holding FGEN

# of Institutions

Shares Held

37.4M

Call Options Held

351K

Put Options Held

105K

View Full List

About FIBROGEN INC

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $72.2M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

More about FGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Fibrogen Inc Transaction History